Omnia Biologics, Inc. and AparnaBio Sign Lentivirus Drug Development Agreement

ROCKVILLE, Md.--(BUSINESS WIRE)--Biologics contract manufacturer Omnia Biologics, Inc. (Omnia) (Rockville, MD) and drug development company Aparna Biosciences Corp. (AparnaBio) (Rockville, MD) today announced a deal for Omnia to provide AparnaBio with process development and production services. Omnia will provide lentiviral vector technical services as well as manufacture of research grade through cGMP grade materials.

MORE ON THIS TOPIC